Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 3/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | BMP1 | P13497 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11075060 | 1.00 | MAPT (0.46) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11076786 | 1.00 | MAPT (0.46) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11067568 | 1.00 | MAPT (0.46) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11070127 | 1.00 | MAPT (0.46) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11077258 | 0.99 | MAPT (0.47) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11069904 | 0.96 | ABCB11 (0.48) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11075276 | 0.94 | ABCB11 (0.50) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11080379 | 0.94 | ABCB11 (0.50) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11021372 | 0.94 | ABCB11 (0.50) | MAPTABCB11LMNAMAPK1CYP1A2 | |
| SCHEMBL11073851 | 0.94 | ABCB11 (0.50) | MAPTABCB11LMNAMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4430339-A | PROPHYLAXIS, METABOLISM, GLUCOSE, FATS, HYPOGLYCEMIC AGENTS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-02-07 | — | — | US | disclosed |
| WO-1982000822-A1 | SUBSTITUTED OXIRANECARBOXYLIC ACIDS,THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | EISTETTER K | 1982-03-18 | — | — | WO | disclosed |